PFEPfizer Inc.
23.68EUR-1.35%Mkt Cap: 148.71B $P/E: 36.37

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The co…

Key Statistics

Company
Market Cap148.71B $
Enterprise Value202.10B $
Revenue (TTM)69.23B $
Gross Profit50.56B $
Net Income (TTM)8.45B $
Revenue/Share12.17 USD
Last Price23.68 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees75.0K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS7170811035
Valuation
P/E (Trailing)36.37
P/E (Forward)
PEG2.58
EV/EBITDA7.33
EV/Revenue2.92
P/S2.10
P/B1.81
EPS (TTM)0.66
EPS (Forward)
52W Range
23.2241% of range24.35
52W High24.35 EUR
52W Low23.22 EUR
Profitability
Gross Margin74.33%
Oper. Margin27.88%
EBITDA Margin39.85%
Profit Margin12.42%
ROE8.99%
ROA3.73%
Growth
Revenue Growth2.60%
Earnings Growth
Cash Flow & Leverage
Operating CF12.72B $
CapEx (TTM)2.86B $
FCF Margin19.60%
FCF Yield9.13%
Net Debt56.28B $
Net Debt/EBITDA2.04
Balance Sheet
Debt/Equity0.74
Current Ratio1.27
Quick Ratio0.85
Book Value/Sh12.99 EUR
Cash/Share2.053 EUR
Dividends
Fwd Div Rate1.510 EUR
Trail. Div Rate1.720 EUR
Div. Yield6.49%
5Y Avg Yield5.08%
Payout Ratio226.32%
Ex-Div DateJul 24, 2026
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.5.70B
Float5.69B
Insiders0.10%
Institutions69.13%
Technical
SMA 5021.95 (+7.9%)
SMA 20022.36 (+5.9%)
Beta0.28
S&P 52W Chg20.80%
Avg Vol (30d)42.13K
Avg Vol (10d)35.76K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)